LIVIVO - Das Suchportal für Lebenswissenschaften

switch to English language
Erweiterte Suche

Suchergebnis

Treffer 1 - 2 von insgesamt 2

Suchoptionen

  1. Artikel: De novo

    Roy, Anindya / Shi, Lei / Chang, Ashley / Dong, Xianchi / Fernandez, Andres / Kraft, John C / Li, Jing / Le, Viet Q / Winegar, Rebecca Viazzo / Cherf, Gerald Maxwell / Slocum, Dean / Daniel Poulson, P / Casper, Garrett E / Vallecillo-Zúniga, Mary L / Valdoz, Jonard Corpuz / Miranda, Marcos C / Bai, Hua / Kipnis, Yakov / Olshefsky, Audrey /
    Priya, Tanu / Carter, Lauren / Ravichandran, Rashmi / Chow, Cameron M / Johnson, Max R / Cheng, Suna / Smith, McKaela / Overed-Sayer, Catherine / Finch, Donna K / Lowe, David / Bera, Asim K / Matute-Bello, Gustavo / Birkland, Timothy P / DiMaio, Frank / Raghu, Ganesh / Cochran, Jennifer R / Stewart, Lance J / Campbell, Melody G / Van Ry, Pam M / Springer, Timothy / Baker, David

    bioRxiv : the preprint server for biology

    2023  

    Abstract: The RGD (Arg-Gly-Asp)-binding integrins αvβ6 and αvβ8 are clinically validated cancer and fibrosis targets of considerable therapeutic importance. Compounds that can discriminate between the two closely related integrin proteins and other RGD integrins, ... ...

    Abstract The RGD (Arg-Gly-Asp)-binding integrins αvβ6 and αvβ8 are clinically validated cancer and fibrosis targets of considerable therapeutic importance. Compounds that can discriminate between the two closely related integrin proteins and other RGD integrins, stabilize specific conformational states, and have sufficient stability enabling tissue restricted administration could have considerable therapeutic utility. Existing small molecules and antibody inhibitors do not have all of these properties, and hence there is a need for new approaches. Here we describe a method for computationally designing hyperstable RGD-containing miniproteins that are highly selective for a single RGD integrin heterodimer and conformational state, and use this strategy to design inhibitors of αvβ6 and αvβ8 with high selectivity. The αvβ6 and αvβ8 inhibitors have picomolar affinities for their targets, and >1000-fold selectivity over other RGD integrins. CryoEM structures are within 0.6-0.7Å root-mean-square deviation (RMSD) to the computational design models; the designed αvβ6 inhibitor and native ligand stabilize the open conformation in contrast to the therapeutic anti-αvβ6 antibody BG00011 that stabilizes the bent-closed conformation and caused on-target toxicity in patients with lung fibrosis, and the αvβ8 inhibitor maintains the constitutively fixed extended-closed αvβ8 conformation. In a mouse model of bleomycin-induced lung fibrosis, the αvβ6 inhibitor potently reduced fibrotic burden and improved overall lung mechanics when delivered via oropharyngeal administration mimicking inhalation, demonstrating the therapeutic potential of
    Sprache Englisch
    Erscheinungsdatum 2023-06-12
    Erscheinungsland United States
    Dokumenttyp Preprint
    DOI 10.1101/2023.06.12.544624
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

  2. Artikel ; Online: De novo design of highly selective miniprotein inhibitors of integrins αvβ6 and αvβ8.

    Roy, Anindya / Shi, Lei / Chang, Ashley / Dong, Xianchi / Fernandez, Andres / Kraft, John C / Li, Jing / Le, Viet Q / Winegar, Rebecca Viazzo / Cherf, Gerald Maxwell / Slocum, Dean / Poulson, P Daniel / Casper, Garrett E / Vallecillo-Zúniga, Mary L / Valdoz, Jonard Corpuz / Miranda, Marcos C / Bai, Hua / Kipnis, Yakov / Olshefsky, Audrey /
    Priya, Tanu / Carter, Lauren / Ravichandran, Rashmi / Chow, Cameron M / Johnson, Max R / Cheng, Suna / Smith, McKaela / Overed-Sayer, Catherine / Finch, Donna K / Lowe, David / Bera, Asim K / Matute-Bello, Gustavo / Birkland, Timothy P / DiMaio, Frank / Raghu, Ganesh / Cochran, Jennifer R / Stewart, Lance J / Campbell, Melody G / Van Ry, Pam M / Springer, Timothy / Baker, David

    Nature communications

    2023  Band 14, Heft 1, Seite(n) 5660

    Abstract: The RGD (Arg-Gly-Asp)-binding integrins αvβ6 and αvβ8 are clinically validated cancer and fibrosis targets of considerable therapeutic importance. Compounds that can discriminate between homologous αvβ6 and αvβ8 and other RGD integrins, stabilize ... ...

    Abstract The RGD (Arg-Gly-Asp)-binding integrins αvβ6 and αvβ8 are clinically validated cancer and fibrosis targets of considerable therapeutic importance. Compounds that can discriminate between homologous αvβ6 and αvβ8 and other RGD integrins, stabilize specific conformational states, and have high thermal stability could have considerable therapeutic utility. Existing small molecule and antibody inhibitors do not have all these properties, and hence new approaches are needed. Here we describe a generalized method for computationally designing RGD-containing miniproteins selective for a single RGD integrin heterodimer and conformational state. We design hyperstable, selective αvβ6 and αvβ8 inhibitors that bind with picomolar affinity. CryoEM structures of the designed inhibitor-integrin complexes are very close to the computational design models, and show that the inhibitors stabilize specific conformational states of the αvβ6 and the αvβ8 integrins. In a lung fibrosis mouse model, the αvβ6 inhibitor potently reduced fibrotic burden and improved overall lung mechanics, demonstrating the therapeutic potential of de novo designed integrin binding proteins with high selectivity.
    Mesh-Begriff(e) Animals ; Mice ; Integrins ; Cell Membrane ; Cryoelectron Microscopy ; Disease Models, Animal ; Pulmonary Fibrosis
    Chemische Substanzen Integrins
    Sprache Englisch
    Erscheinungsdatum 2023-09-13
    Erscheinungsland England
    Dokumenttyp Journal Article ; Research Support, N.I.H., Extramural ; Research Support, Non-U.S. Gov't
    ZDB-ID 2553671-0
    ISSN 2041-1723 ; 2041-1723
    ISSN (online) 2041-1723
    ISSN 2041-1723
    DOI 10.1038/s41467-023-41272-z
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

Zum Seitenanfang